The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 711-718.e2 , March 2010

Naturally processed T cell–activating peptides of the major birch pollen allergen

  • Sonja Mutschlechner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    • ,
  • Matthias Egger, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • ,
  • Peter Briza, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • ,
  • Michael Wallner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • ,
  • Peter Lackner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • ,
  • Anette Karle, PhD

      Affiliations

    • F. Hoffmann-La Roche Ltd, Immunosafety, Non-Clinical Safety, Basel, Switzerland
    • ,
  • Anne B. Vogt, PhD

      Affiliations

    • F. Hoffmann-La Roche Ltd, Immunosafety, Non-Clinical Safety, Basel, Switzerland
    • ,
  • Gottfried F. Fischer, MD

      Affiliations

    • Clinical Department for Blood Group Serology, University Clinic for Blood Group Serology and Transfusion Medicine, Vienna, Austria
    • ,
  • Barbara Bohle, PhD

      Affiliations

    • Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationReprint requests: Barbara Bohle, PhD, Institute of Pathophysiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • These authors are cosenior authors of this article.
    • ,
  • Fatima Ferreira, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • Corresponding Author InformationFatima Ferreira, PhD, Department of Molecular Biology, University of Salzburg, Hellbrunner Strasse 34, 5020 Salzburg, Austria.
    • These authors are cosenior authors of this article.

Received 10 July 2009 ,Revised 6 October 2009 ,Accepted 29 October 2009.

References 

  1. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199:1567–1575
  2. Bohle B, Schwihla H, Hu HZ, Friedl-Hajek R, Sowka S, Ferreira F, et al. Long-lived Th2 clones specific for seasonal and perennial allergens can be detected in blood and skin by their TCR-hypervariable regions. J Immunol. 1998;160:2022–2027
  3. Christensen LH, Holm J, Lund G, Riise E, Lund K. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol. 2008;122:298–304
  4. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med. 1999;189:1885–1894
  5. Bohle B, Zwolfer B, Heratizadeh A, Jahn-Schmid B, Antonia YD, Alter M, et al. Cooking birch pollen-related food: divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo. J Allergy Clin Immunol. 2006;118:242–249
  6. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994;76:287–299
  7. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17–58
  8. Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev. 2007;219:143–156
  9. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol. 1995;154:6285–6290
  10. Maurer D, Fiebiger E, Reininger B, Ebner C, Petzelbauer P, Shi GP, et al. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J Immunol. 1998;161:2731–2739
  11. Novak N, Tepel C, Koch S, Brix K, Bieber T, Kraft S. Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors. J Clin Invest. 2003;111:1047–1056
  12. Bohle B. T-cell epitopes of food allergens. Clin Rev Allergy Immunol. 2006;30:97–108
  13. Woodfolk JA. T-cell responses to allergens. J Allergy Clin Immunol. 2007;119:280–294quiz 95-96
  14. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 1992;358:764–768
  15. Lippolis JD, White FM, Marto JA, Luckey CJ, Bullock TN, Shabanowitz J, et al. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol. 2002;169:5089–5097
  16. Malcherek G, Gnau V, Stevanovic S, Rammensee HG, Jung G, Melms A. Analysis of allele-specific contact sites of natural HLA-DR17 ligands. J Immunol. 1994;153:1141–1149
  17. Vignali DA, Strominger JL. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J Exp Med. 1994;179:1945–1956
  18. Carson RT, Vignali KM, Woodland DL, Vignali DA. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity. 1997;7:387–399
  19. Moudgil KD, Sercarz EE, Grewal IS. Modulation of the immunogenicity of antigenic determinants by their flanking residues. Immunol Today. 1998;19:217–220
  20. Ferreira F, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R, et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med. 1996;183:599–609
  21. Ferreira F, Ebner C, Kramer B, Casari G, Briza P, Kungl AJ, et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J. 1998;12:231–242
  22. Ebner C, Szepfalusi Z, Ferreira F, Jilek A, Valenta R, Parronchi P, et al. Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol. 1993;150:1047–1054
  23. Jahn-Schmid B, Radakovics A, Luttkopf D, Scheurer S, Vieths S, Ebner C, et al. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. J Allergy Clin Immunol. 2005;116:213–219
  24. Friedl-Hajek R, Spangfort MD, Schou C, Breiteneder H, Yssel H, Joost van Neerven RJ. Identification of a highly promiscuous and an HLA allele-specific T-cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons. Clin Exp Allergy. 1999;29:478–487
  25. Breiteneder H, Scheiner O, Hajek R, Hulla W, Huttinger R, Fischer G, et al. Diversity of TCRAV and TCRBV sequences used by human T-cell clones specific for a minimal epitope of Bet v 1, the major birch pollen allergen. Immunogenetics. 1995;42:53–58
  26. Van Overtvelt L, Wambre E, Maillere B, von Hofe E, Louise A, Balazuc AM, et al. Assessment of Bet v 1-specific CD49 + T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol. 2008;180:4514–4522
  27. Jahn-Schmid B, Fischer GF, Bohle B, Fae I, Gadermaier G, Dedic A, et al. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 ∗01. J Allergy Clin Immunol. 2005;115:399–404
  28. Gerstmayr M, Ilk N, Schabussova I, Jahn-Schmid B, Egelseer EM, Sleytr UB, et al. A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells. J Immunol. 2007;179:7270–7275
  29. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 2005;307:1630–1634
  30. Rohn TA, Reitz A, Paschen A, Nguyen XD, Schadendorf D, Vogt AB, et al. A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope. Cancer Res. 2005;65:10068–10078
  31. Rammensee HG. Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol. 1995;7:85–96
  32. Carmicle S, Dai G, Steede NK, Landry SJ. Proteolytic sensitivity and helper T-cell epitope immunodominance associated with the mobile loop in Hsp10s. J Biol Chem. 2002;277:155–160
  33. Delamarre L, Couture R, Mellman I, Trombetta ES. Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J Exp Med. 2006;203:2049–2055
  34. Ebner C, Schenk S, Najafian N, Siemann U, Steiner R, Fischer GW, et al. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol. 1995;154:1932–1940
  35. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol. 2000;1:311–316

 Supported by P10150 of the Österreichische Nationalbank, the Christian Doppler Laboratory for Allergy Diagnosis and Therapy, and the Christian Doppler Laboratory for Immunomodulation, Austria.

 Disclosure of potential conflict of interest: F. Ferreira has received research support from Biomay AG, the Austrian Science Fund, the Christian Doppler Research Association, and the Austrian National Bank and has provided legal consultation services or expert witness testimony relevant to Indoor Biotechnologies and AllergenOnline Database. B. Bohle has received research support from the Austrian Science Fund and the Christian Doppler Laboratory. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01629-7

doi: 10.1016/j.jaci.2009.10.052

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 711-718.e2 , March 2010

Article Tools

* Image Usage & Resolution